Dr. Gul is currently open to mentoring Master's and Ph.D. students in the field of biological…
introduction/brief CV
Dr. Rukhsana Gul is a Principal Investigator and Associate Professor at the Obesity Research Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia. She is a cardiovascular scientist with expertise in cell signaling, molecular biology, cardiovascular pharmacology, and nanomedicine. Dr. Gul earned her Ph.D. in Medicine from Jeonbuk National University, South Korea. She pursued postdoctoral research training at Chonbuk National University, South Korea, and the University of Missouri, USA. Her research has contributed to the understanding of angiotensin II-mediated cardiovascular signaling, β-adrenergic receptor biology, oxidative stress, mitochondrial dysfunction, and cardiac injury, leading to the identification of novel therapeutic targets and strategies for cardiovascular disease.Her current research focuses on the molecular mechanisms linking metabolic disorders and cardiovascular disease, with particular emphasis on metabolic syndrome, mitochondrial dysfunction, cardiac hypertrophy, fibrosis, and cardiovascular injury. Her laboratory investigates the therapeutic potential of β-adrenergic receptor blockers, nanoceria and other nanomaterials, alongside molecular and proteomic approaches to identify novel mechanisms and therapeutic targets. In recognition of her research contributions, Dr. Gul has been the recipient of numerous distinguished awards including Best Dissertation Award from Jeonbuk National University, Young Scientist Award, Young Investigator Award from Veterans Affairs, University of Missouri and outstanding research in her doctoral and postdoctoral training. She has also been awarded competitive research funding and has presented her work at international scientific conferences. Dr. Gul aims to improve the understanding of cardiovascular complications associated with metabolic diseases and to contribute to the development of innovative treatments through an interdisciplinary research program integrating cardiovascular biology, metabolic research, pharmacology, nanotechnology and omics approaches.
areas of expertise
Cardiovascular Disease and Cardiometabolic Research Cardiovascular Cell Signaling Renin–Angiotensin–Aldosterone System (RAAS) β-Adrenergic Receptor Signaling and Pharmacology Obesity and Metabolic Disorders Mitochondrial Dysfunction and Oxidative Stress Cardiac Hypertrophy and Myocardial Injury Nanomedicine and Nanomaterials Nanoceria and Nanozyme-Based Therapeutics Proteomics and Molecular Profiling Cardiovascular Pharmacology Type 2 Diabetes and Cardiovascular Complications Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)